TY - JOUR
T1 - Electroacupuncture for abdominal pain relief in patients with acute pancreatitis
T2 - A three-arm randomized controlled trial
AU - Kee Jang, Dong
AU - Kyu Lee, Jun
AU - Yung Jung, Chan
AU - Ho Kim, Kyung
AU - Ra Kang, Ha
AU - Sun Lee, Yeon
AU - Hwa Yoon, Jong
AU - Ro Joo, Kwang
AU - Kyu Chae, Min
AU - Hyeon Baek, Yong
AU - Seo, Byung Kwan
AU - Hyub Lee, Sang
AU - Lim, Chiyeon
N1 - Publisher Copyright:
© 2023
PY - 2023/11
Y1 - 2023/11
N2 - Background: Electroacupuncture (EA) may reduce the severity of acute pancreatitis (AP) and provide additional pain relief in patients with chronic pancreatitis. However, the ability of EA to relieve pain in patients with AP has not been well documented. Objective: This study was undertaken to compare the pain-relieving effects of EA and conventional treatment in patients with AP. Design, setting, participants and interventions: This study was conducted using a randomized, controlled, three-arm, parallel-group and multi-center design. Patients diagnosed with AP were randomly and equally assigned to EA1, EA2 or control groups. All participants received conventional standard-of-care therapy for AP. Local EA alone was administered in EA1, and local plus distal EA was given in EA2. Local EA included two abdominal acupoints, while distal EA included twelve peripheral acupoints. EA groups underwent one session of EA daily for 4 days (days 1–4), or until pain was resolved or discharged. Main outcome measures: The primary outcome measure was the change in the visual analogue scale (VAS; 0–100) pain score between baseline and day 5. Results: Eighty-nine participants were randomized into EA1, EA2 and control groups, and 88 (EA1, 30; EA2, 29; control, 29) were included in the full-analysis set. VAS score change (median [interquartile range]) on day 5 was (12.3 ± 22.5) in the EA1 group, (10.3 ± 21.5) in the EA2 group, and (8.9 ± 15.2) in the control group. There were not significant differences in the change in VAS score among treatments (P = 0.983). However, time to food intake was significantly shorter in the EA group (EA1 + EA2) than in the control group (median 2.0 days vs 3.0 days), with a hazard ratio of 0.581 (P = 0.022; 95% CI, 0.366–0.924). No significant adverse events occurred. Conclusion: EA treatment did not significantly reduce pain after 4 days of treatment in patients with AP-associated abdominal pain but significantly reduced time to first food intake. Trial registration: ClinicalTrials.gov identifier NCT03173222. Please cite this article as: Jang DK, Lee JK, Jung CY, Kim KH, Kang HR, Lee YS, Yoon JH, Joo KR, Chae MK, Baek YH, Seo BK, Lee SH, Lim C. Electroacupuncture for abdominal pain relief in patients with acute pancreatitis: A three-arm randomized controlled trial. J Integr Med. 2023; 21(6): 537–542.
AB - Background: Electroacupuncture (EA) may reduce the severity of acute pancreatitis (AP) and provide additional pain relief in patients with chronic pancreatitis. However, the ability of EA to relieve pain in patients with AP has not been well documented. Objective: This study was undertaken to compare the pain-relieving effects of EA and conventional treatment in patients with AP. Design, setting, participants and interventions: This study was conducted using a randomized, controlled, three-arm, parallel-group and multi-center design. Patients diagnosed with AP were randomly and equally assigned to EA1, EA2 or control groups. All participants received conventional standard-of-care therapy for AP. Local EA alone was administered in EA1, and local plus distal EA was given in EA2. Local EA included two abdominal acupoints, while distal EA included twelve peripheral acupoints. EA groups underwent one session of EA daily for 4 days (days 1–4), or until pain was resolved or discharged. Main outcome measures: The primary outcome measure was the change in the visual analogue scale (VAS; 0–100) pain score between baseline and day 5. Results: Eighty-nine participants were randomized into EA1, EA2 and control groups, and 88 (EA1, 30; EA2, 29; control, 29) were included in the full-analysis set. VAS score change (median [interquartile range]) on day 5 was (12.3 ± 22.5) in the EA1 group, (10.3 ± 21.5) in the EA2 group, and (8.9 ± 15.2) in the control group. There were not significant differences in the change in VAS score among treatments (P = 0.983). However, time to food intake was significantly shorter in the EA group (EA1 + EA2) than in the control group (median 2.0 days vs 3.0 days), with a hazard ratio of 0.581 (P = 0.022; 95% CI, 0.366–0.924). No significant adverse events occurred. Conclusion: EA treatment did not significantly reduce pain after 4 days of treatment in patients with AP-associated abdominal pain but significantly reduced time to first food intake. Trial registration: ClinicalTrials.gov identifier NCT03173222. Please cite this article as: Jang DK, Lee JK, Jung CY, Kim KH, Kang HR, Lee YS, Yoon JH, Joo KR, Chae MK, Baek YH, Seo BK, Lee SH, Lim C. Electroacupuncture for abdominal pain relief in patients with acute pancreatitis: A three-arm randomized controlled trial. J Integr Med. 2023; 21(6): 537–542.
KW - Abdominal pain
KW - Acute pancreatitis
KW - Electroacupuncture
KW - Pain management
KW - Randomized controlled trial
UR - http://www.scopus.com/inward/record.url?scp=85176951525&partnerID=8YFLogxK
U2 - 10.1016/j.joim.2023.10.004
DO - 10.1016/j.joim.2023.10.004
M3 - Article
C2 - 37973472
AN - SCOPUS:85176951525
SN - 2095-4964
VL - 21
SP - 537
EP - 542
JO - Journal of Integrative Medicine
JF - Journal of Integrative Medicine
IS - 6
ER -